Effects of Bariatric Surgery on the Pharmacokinetics of Cardiovascular Drugs: A Systematic Review and Meta-Analysis - PubMed
2 days ago
- #Cardiovascular Drugs
- #Bariatric Surgery
- #Pharmacokinetics
- Bariatric surgery impacts the pharmacokinetics of cardiovascular drugs, requiring individualized dose adjustments.
- Systematic review and meta-analysis of 24 studies show varied effects on different drug classes.
- Anticoagulants like rivaroxaban and apixaban show no significant changes in pharmacokinetics post-surgery.
- Warfarin dosing requirements slightly decrease after bariatric surgery.
- Beta-blockers exhibit drug-specific changes: atenolol Cmax increases, while carvedilol and controlled-release metoprolol decrease.
- Atorvastatin absorption is delayed post-surgery, with prolonged Tmax but no significant change in Cmax.
- Rosuvastatin and simvastatin show transient exposure changes that normalize over time.
- Findings support the need for tailored dosing guidelines for cardiovascular drugs post-bariatric surgery.